Logo image of BAMI.MI

BANCO BPM SPA (BAMI.MI) Stock Fundamental Analysis

BIT:BAMI - Euronext Milan - IT0005218380 - Common Stock - Currency: EUR

9.86  -0.1 (-0.98%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BAMI. BAMI was compared to 99 industry peers in the Banks industry. There are concerns on the financial health of BAMI while its profitability can be described as average. BAMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BAMI was profitable.
In the past 5 years BAMI has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: BAMI reported negative operating cash flow in multiple years.
BAMI.MI Yearly Net Income VS EBIT VS OCF VS FCFBAMI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

With an excellent Return On Assets value of 1.63%, BAMI belongs to the best of the industry, outperforming 91.40% of the companies in the same industry.
With an excellent Return On Equity value of 22.16%, BAMI belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
Industry RankSector Rank
ROA 1.63%
ROE 22.16%
ROIC N/A
ROA(3y)0.65%
ROA(5y)0.45%
ROE(3y)9.14%
ROE(5y)6.39%
ROIC(3y)N/A
ROIC(5y)N/A
BAMI.MI Yearly ROA, ROE, ROICBAMI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

BAMI has a Profit Margin of 29.46%. This is in the better half of the industry: BAMI outperforms 79.57% of its industry peers.
In the last couple of years the Profit Margin of BAMI has grown nicely.
BAMI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 29.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y38.25%
PM growth 5Y16.59%
GM growth 3YN/A
GM growth 5YN/A
BAMI.MI Yearly Profit, Operating, Gross MarginsBAMI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

BAMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BAMI has been reduced compared to 1 year ago.
The number of shares outstanding for BAMI has been reduced compared to 5 years ago.
BAMI has a better debt/assets ratio than last year.
BAMI.MI Yearly Shares OutstandingBAMI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BAMI.MI Yearly Total Debt VS Total AssetsBAMI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

A Debt/Equity ratio of 1.65 is on the high side and indicates that BAMI has dependencies on debt financing.
BAMI's Debt to Equity ratio of 1.65 is in line compared to the rest of the industry. BAMI outperforms 58.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.65
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.28%
BAMI.MI Yearly LT Debt VS Equity VS FCFBAMI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BAMI.MI Yearly Current Assets VS Current LiabilitesBAMI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.01% over the past year.
Measured over the past years, BAMI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.27% on average per year.
BAMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.77%.
Measured over the past years, BAMI shows a small growth in Revenue. The Revenue has been growing by 2.26% on average per year.
EPS 1Y (TTM)76.01%
EPS 3Y49.87%
EPS 5Y19.27%
EPS Q2Q%85.16%
Revenue 1Y (TTM)-10.77%
Revenue growth 3Y8.5%
Revenue growth 5Y2.26%
Sales Q2Q%108.36%

3.2 Future

The Earnings Per Share is expected to decrease by -1.36% on average over the next years.
BAMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.
EPS Next Y-9.02%
EPS Next 2Y-5%
EPS Next 3Y-1.36%
EPS Next 5YN/A
Revenue Next Year-1.21%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BAMI.MI Yearly Revenue VS EstimatesBAMI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAMI.MI Yearly EPS VS EstimatesBAMI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.59, the valuation of BAMI can be described as very cheap.
96.77% of the companies in the same industry are more expensive than BAMI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BAMI to the average of the S&P500 Index (29.35), we can say BAMI is valued rather cheaply.
The Price/Forward Earnings ratio is 9.59, which indicates a very decent valuation of BAMI.
The rest of the industry has a similar Price/Forward Earnings ratio as BAMI.
BAMI is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.59
Fwd PE 9.59
BAMI.MI Price Earnings VS Forward Price EarningsBAMI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAMI.MI Per share dataBAMI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2Y-5%
EPS Next 3Y-1.36%

6

5. Dividend

5.1 Amount

BAMI has a Yearly Dividend Yield of 10.04%, which is a nice return.
Compared to an average industry Dividend Yield of 5.06, BAMI pays a better dividend. On top of this BAMI pays more dividend than 100.00% of the companies listed in the same industry.
BAMI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-5%
EPS Next 3Y-1.36%
BAMI.MI Yearly Income VS Free CF VS DividendBAMI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

BANCO BPM SPA

BIT:BAMI (3/7/2025, 7:00:00 PM)

9.86

-0.1 (-0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-07 2025-05-07
Inst Owners39.25%
Inst Owner ChangeN/A
Ins Owners2.15%
Ins Owner ChangeN/A
Market Cap14.94B
Analysts75
Price Target9.41 (-4.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)56.48%
Min Revenue beat(2)4.16%
Max Revenue beat(2)108.79%
Revenue beat(4)3
Avg Revenue beat(4)28.01%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)108.79%
Revenue beat(8)6
Avg Revenue beat(8)14.24%
Revenue beat(12)10
Avg Revenue beat(12)32.69%
Revenue beat(16)14
Avg Revenue beat(16)26.52%
PT rev (1m)12.99%
PT rev (3m)21.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.94%
EPS NY rev (3m)11.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.12%
Revenue NY rev (3m)3.94%
Valuation
Industry RankSector Rank
PE 4.59
Fwd PE 9.59
P/S 1.36
P/FCF N/A
P/OCF N/A
P/B 1.02
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)2.15
EY21.81%
EPS(NY)1.03
Fwd EY10.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.25
BVpS9.64
TBVpS8.81
PEG (NY)N/A
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 22.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 29.46%
GM N/A
FCFM N/A
ROA(3y)0.65%
ROA(5y)0.45%
ROE(3y)9.14%
ROE(5y)6.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y38.25%
PM growth 5Y16.59%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC5.28%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.01%
EPS 3Y49.87%
EPS 5Y19.27%
EPS Q2Q%85.16%
EPS Next Y-9.02%
EPS Next 2Y-5%
EPS Next 3Y-1.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.77%
Revenue growth 3Y8.5%
Revenue growth 5Y2.26%
Sales Q2Q%108.36%
Revenue Next Year-1.21%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.68%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A